Improved survival in AML with higher anthracycline doses
Author: Tamer M. Fouad, M.D. Submitted: September 29, 2009. Updated: September 29, 2009. Category: Hematology | Bone Marrow Transplantation | Oncology | Pharmacy
Younger patients with acute myeloid leukemia (AML) that receive higher doses of anthracyclines during induction chemotherapy are reported to have better complete remission rates in most studies. As of yet, studies have failed to show an improved surivival… Read more... (Comments: 0)


